Navigation Links
Phase 2b Study of Boehringer Ingelheim's Interferon-Free Hepatitis C Treatment Shows Undetectable Virus in HCV Genotype-1 Patients 12 Weeks After Treatment Ended (SVR12)
Date:4/19/2012

ot available due to treatment duration  

Investigators reported breakthrough broken out by genotype and IL-28B status. In GT1b and GT1a-CC patients, breakthrough occurred in 7 percent of patients in Arm A, 11 percent of patients in Arm B, 19 percent of patients in Arm C, 9 percent of patients in Arm D, and 29 percent of patients in Arm E (no RBV arm). In GT1a non-CC patients, breakthrough occurred in 40 percent of patients in Arm A, 50 percent of patients in Arm B, 25 percent of patients in Arm C, 64 percent of patients in Arm D, and 91 percent of patients in Arm E (no RBV arm).

In this study, the most common adverse events (AEs) were skin (photosensitivity, rash), gastrointestinal (GI) disorders (vomiting, diarrhea), and jaundice due to unconjugated hyperbilirubinemia. Treatment discontinuations due to AEs correlated with increased dosing frequency and treatment duration, with discontinuations ranging from 4.9 percent in Arm A (16 weeks) to 24.7 percent in Arm C (40 weeks). In the arm with BID dosing of BI 207127 (Arm D), discontinuations were 7.7 percent. BID dosing of BI 207127 is planned for Phase 3 investigation.

Other BI data being presented at the EASL Annual Meeting include: Poster PresentationsTitleLead Author Presentation Details SOUND-C2 interim analysis:
The efficacy and safety of the
interferon-free combination of
BI 201335 and BI 207127 in
genotype-1 HCV patients with
cirrhosis

V. Soriano

Late Breaker Poster# 1420

 

Date: Thur, April 19

Time: 12:00 - 1:30 p.m.
CEST/ 6:00 - 7:30 a.m. EDT

 Characterization of HCV NS3
variants that emerged during
virologic breakthrough and
relapse from BI 201335 Phase
2 SILEN-C2 study in
pegylated-interferon plus
ribavirin treatment-
experienced patients

G. Kukolj

Poster# 1185

 

Date: Sat, April 21

Time: 12:30 – 1:30 p.m.
CEST/ 6:30 &
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. CrystalGenomics Announces Positive Results from Phase 2b Osteoarthritis Study of CG100649
2. Morphotek®, Inc. Announces Initiation of MORAb-004 Phase 2 Study in Metastatic Colorectal Cancer
3. Encouraging Phase III Study Results Show PET Imaging with Florbetaben Reliably Detects Beta-Amyloid in the Brain
4. QRxPharma Successfully Completes Phase 1 Studies for MoxDuo® CR
5. Enanta Announces Positive Phase 2 Results From Interferon-Free Combination Studies with ABT-450 for Hepatitis C Treatment to be Presented at EASL
6. UCB and Amgen Initiate Sclerostin Antibody Phase 3 Program in Patients With Postmenopausal Osteoporosis
7. Bionovos Independent Data Safety Monitoring Board Recommends Continuation of Phase 3 Study for Menerba™
8. Neurocrine Announces Phase II Results of VMAT2 Inhibitor NBI-98854 for Treatment of Tardive Dyskinesia
9. iBio Announces Successful Completion of H1N1 Influenza Vaccine Phase 1 Clinical Trial
10. Avaxia Biologics Awarded $1.5 Million Phase II SBIR Grant from NIH to Develop Oral Antibody Therapeutic for Inflammatory Bowel Disease
11. Johnson & Johnson to Provide Webcast Presentation of XARELTO® (rivaroxaban) Phase 3 Clinical Data Presented at the American College of Cardiologys Annual Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015  BioDelivery Sciences International, Inc. (NASDAQ: ... and Chief Executive Officer of BDSI, will present at two important ... Conference Tuesday, June 2 8:30 AM Eastern Time Grand Hyatt, ... William Blair 35 th Annual Growth Stock Conference Tuesday, ... Seasons Hotel, Chicago, IL , ...
(Date:5/27/2015)... Biomedical Catalyst Award to ... Cancer  Crescendo Biologics Limited (Crescendo) today ... (ADC) programme with the support of a Biomedical ... UK. This feasibility award will enable the validation ... novel product format based on Crescendo,s Humabody™ antibody ...
(Date:5/26/2015)... 2015  AbbVie (NYSE: ABBV ) presented ... of its investigational, all-oral, interferon (IFN)- and ribavirin ... the Annual Meeting of the Japan Society of ... 1 GIFT-I evaluated genotype 1b (GT1b) chronic ... and without cirrhosis, who were either treatment-naïve or ...
Breaking Medicine Technology:BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference and the William Blair Growth Stock Conference 2BioDelivery Sciences to Present at the Jefferies 2015 Healthcare Conference and the William Blair Growth Stock Conference 3Crescendo Biologics Expands ADC Programmes with Innovate UK Funding Award 2AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 2AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 3AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 4AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 5AbbVie Presents New Data for its Investigational Hepatitis C Treatment in Japanese Patients With and Without Cirrhosis 6
... Stryker Corporation (NYSE: SYK ) today announced that the U.S. ... undertaken to address issues raised in two Warning Letters received in 2007 ... , , ... certain quality system requirements at its reconstructive implant manufacturing facility in ...
... China , May 19 /PRNewswire-Asia-FirstCall/ -- ... the "Company"),(OTC Bulletin Board: CRUI), a manufacturer and distributor ... pharmaceuticals, construction materials,PVC products, foods and beverages and cosmetics, ... March 31, 2010 . , , ...
Cached Medicine Technology:Stryker Announces Resolution of Two FDA Warning Letters 2China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 2China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 3China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 4China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 5China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 6China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 7China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 8China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 9China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 10China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 11China Ruitai International Holdings Co., Ltd. Reports Results for the First Quarter 2010 12
(Date:5/27/2015)... silver spring, MD (PRWEB) May 27, 2015 ... Company in USA, helped its client to launch an ... Payment app allows merchants to accept credit, debit and ... be downloaded from Google Play at: https://play.google.com/store/apps/details?id=com.simpalm.paymentgateway . ... Jan 2013 and has been recently updated by SIMpalm. ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 Kudolife ... its much-anticipated Apple Watch release available at ... health-conscious users to track their calories and activities with ... background to identify activity type for accurate tracking. , ... with the sought-after Apple Watch, which will allow users ...
(Date:5/27/2015)... HomeTown Health, along with other physician health ... on May 13 & 14. In each city, a ... with the group of representatives and receive assistance, answers ... attended. , Referred to as the "Rural Physician ... Health Information Technology and ICD-10 resources with primarily Physicians ...
(Date:5/26/2015)... Local dentist Abid Paghdiwala is now helping Philadelphia ... of Pearl Dental Arts recently became an American Academy ... leading national organization for dentists who treat snoring and ... alternative treatment to the standard continuous positive airway pressure ... CPAP machine, which includes a face mask, tubing and ...
(Date:5/26/2015)... May 27, 2015 Securityhunter ... (MATOC) by the United States Department of Health and ... The MATOC was awarded through the General ... (FSS) for the PSC, which is a fee-for-service agency. ... one year options, and is an enterprise–wide physical security ...
Breaking Medicine News(10 mins):Health News:Forte Payment System Launches Android Version of Payment App 2Health News:Kudolife Launches into Apple Watch App Market with Newest Release 2Health News:Kudolife Launches into Apple Watch App Market with Newest Release 3Health News:HomeTown Health Leads Rural Physician Bus Tour; Brings Resources and Education to North Georgia 2Health News:HomeTown Health Leads Rural Physician Bus Tour; Brings Resources and Education to North Georgia 3Health News:Philadelphia sleep apnea dentist now offers oral appliances to treat snoring 2Health News:Securityhunter Has Been Awarded a Multiple Award Task Order Contract (MATOC) by the Department of Health and Human Services 2
... in the Journal Psychological bulletin that having positive emotions ... better health and long life.// This research study was ... emotions had a direct impact on health as they ... protects from psychological stress. The researchers feel that interpreting ...
... protein was found to be responsible for transferring ... very important for reducing oxidative stress as Cysteine ... radical scavenging activity in brain.// Free radicals are ... antioxidants. Professor Raymond Swanson and his team from ...
... Gladstone Institute of Neurological Disease have found that the ... disease //that acts by inactivating the conversion of glucose ... fragments released from apoE. ,The apoE protein ... by not providing the glucose present in the brain ...
... at the University of Toronto stimulates the muscles of ... walking function in those with no hope of walking.// ... functional electrical stimulation (FES), a process that sends controlled ... can help patients enhance their walking skills by improving ...
... Institute (SERI) found that increasing the contrast of details ... the visually impaired. // ,The U.S. study provides ... help millions suffering eye diseases. People who may benefit ... degeneration, diabetic retinopathy and other causes of low vision. ...
... and community medicine and colleagues developed the latest tool for ... a tool which is called the Newest vital sign. It ... on an ice cream nutrition label. Based on the number ... can be calculated. , Then it is for ...
Cached Medicine News:Health News:Visually impaired prefer specially enhanced TV 2Health News:Visually impaired prefer specially enhanced TV 3
Titanium. Straight shafts with 6 mm platform and Pierse tips. Flat serrated handle with dull finish....
0.12 mm, 1 x 2 teeth set at 45 degrees with 5 mm tying platform. Serrated handle with polished finish....
Serrated handle with 7 mm tying platform and polished finish. Teeth: 0.25 mm, 2 x 2 set at 45 degrees....
5 mm tying platform, serrated cross action handle with polished finish. Teeth: 0.10 mm, 1 x 2 set at 45 degrees....
Medicine Products: